NCT06058052

Brief Summary

To evaluate the clinical predictors of OSA in patients with ILD

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
81

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 22, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 28, 2023

Completed
22 days until next milestone

Study Start

First participant enrolled

October 20, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 28, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2024

Completed
Last Updated

September 28, 2023

Status Verified

April 1, 2023

Enrollment Period

11 months

First QC Date

September 22, 2023

Last Update Submit

September 22, 2023

Conditions

OSA

Outcome Measures

Primary Outcomes (1)

  • Predictors of OSA in patients with ILD

    By clinical history ,examination, BMI

    Baseline

Secondary Outcomes (1)

  • Prevalence of OSA among patients with ILD Presented To Chest Department in Assiut University Hospital

    base line

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients admitted to Assiut University Hospital diagnosed as interstitial lung disease risky for OSA will be included from June 2023 to January 2024.

You may qualify if:

  • Patients presented to Chest Department with interstitial lung disease will be included, screened for OSA.

You may not qualify if:

  • Age: less than 18 years. Unstable patients or need for ICU admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Mohamed yassen, MD

    Assiut University

    STUDY CHAIR

Central Study Contacts

Hend saleh, MD

CONTACT

01098988712hend.m.saleh@gmail.com

Mohamed Khalaf, MD

CONTACT

01026600071dr.mga2011@aun.edu.eg

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

September 22, 2023

First Posted

September 28, 2023

Study Start

October 20, 2023

Primary Completion

September 28, 2024

Study Completion

December 25, 2024

Last Updated

September 28, 2023

Record last verified: 2023-04